Novo Nordisk A/S B SHRS AdrhNVOHETF
13F holders, Q1 2026 (March 31)1holders −1
1new positions
0sold out
$20.60avg. 13F price*
At the end of Q1 2026, 1 institutions reported holding Novo Nordisk A/S B SHRS Adrh (NVOH) in their 13F filings, down 1 from Q3 2025. 1 opened new positions and 0 sold out. The largest holder was UBS Group AG ($206).
- Company
- Novo Nordisk A/S B SHRS Adrh
- Filed as
- PRECIDIAN ETFS TR (Q1 2026)
- CUSIP
- 74016W841
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $206 |
| Exits | 0 | $0 |
All 13F filers, Q3 2025 → Q1 2026: 10 shares bought, net +10 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| UBS Group AG | 0.00% | New | 10 | $206 |
"% of holder's portfolio" is NVOH's weight in each manager's 13F, not the share of Novo Nordisk A/S B SHRS Adrh the manager owns.